These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8479512)
1. 15 drug companies to share data on AIDS therapies. Gershon D Nature; 1993 Apr; 362(6423):780. PubMed ID: 8479512 [No Abstract] [Full Text] [Related]
2. Production of low cost AIDS drugs to continue in Brazil. Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899 [No Abstract] [Full Text] [Related]
3. [International collaboration among firms for the development of drugs for AIDS. An agreement among 15 pharmaceutical firms]. Minerva Med; 1993; 84(7-8):XIV. PubMed ID: 8414128 [No Abstract] [Full Text] [Related]
4. Rights, patents, markets and the global AIDS pandemic. Gathii JT Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139 [No Abstract] [Full Text] [Related]
5. Future of ICC debated. Inter-Company Collaboration for AIDS Drug Development. Smart T GMHC Treat Issues; 1995 Jun; 9(6):9. PubMed ID: 11362692 [TBL] [Abstract][Full Text] [Related]
6. AIDS researchers, activists to face off over drug studies. Chase M Wall St J (East Ed); 2005 May; ():B7. PubMed ID: 16134271 [No Abstract] [Full Text] [Related]
7. USA: drug firms to collaborate in AIDS trials. McCarthy M Lancet; 1993 May; 341(8853):1141-2. PubMed ID: 8097819 [No Abstract] [Full Text] [Related]
8. International intellectual property, access to health care, and human rights: South Africa v. United States. Nagan WP Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137 [No Abstract] [Full Text] [Related]
9. Drug companies seek trial participants. AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432 [TBL] [Abstract][Full Text] [Related]
10. The fine line between education and marketing. Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352 [TBL] [Abstract][Full Text] [Related]
11. Brazil's WTO case has no bearing on AIDS. Holmer AF Nature; 2001 Jun; 411(6841):992. PubMed ID: 11429572 [No Abstract] [Full Text] [Related]
12. AIDS drugs in research. Hosp Pharm; 1990 Jun; 25(6):572-3, 576. PubMed ID: 10104831 [No Abstract] [Full Text] [Related]
13. Fear of AIDS propels sale of antiviral drugs in Europe. Ann Allergy; 1989 May; 62(5):A28. PubMed ID: 2719344 [No Abstract] [Full Text] [Related]
15. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]
16. South African firm gets US approval for AIDS drugs. AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15846847 [No Abstract] [Full Text] [Related]
17. ["We have a high research potential." Prof. Dr. med. H. D. Schlumberger, Bayer, and Dr. E. Schrinner, Hoechst, interpret the cooperation of both companies in AIDS research. Interview by T. U. Keil]. Schlumberger HD; Schrinner E Fortschr Med; 1988 Oct; 106(29):22-3. PubMed ID: 3234996 [No Abstract] [Full Text] [Related]
18. Whatever happened to expanded access? Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564 [TBL] [Abstract][Full Text] [Related]
19. Nurses and others settle with maker of AIDS drug. Ohio Nurses Rev; 1993 Jun; 68(4):5. PubMed ID: 8327251 [No Abstract] [Full Text] [Related]